Pedal Bcu, Llc
Clinical trials sponsored by Pedal Bcu, Llc, explained in plain language.
-
Could a new drug combo help kids beat leukemia again?
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy helps children and young adults with relapsed acute myeloid leukemia (AML) live longer. About 130 participants aged 29 days to 21 years will be randomly assigned to receive chemotherapy with or without v…
Phase: PHASE3 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for kids with relapsed leukemia: targeted drug plus chemo enters trial
Disease control Recruiting nowThis early-phase trial tests a new targeted drug called ziftomenib combined with chemotherapy in children and young adults (up to age 21) whose acute leukemia has returned or not responded to standard treatment. The study focuses on finding the safest dose and understanding how t…
Phase: PHASE1 • Sponsor: PedAL BCU, LLC • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New screening trial aims to match kids with relapsed leukemia to better treatments
Knowledge-focused Recruiting nowThis study screens children and young adults (up to age 22) whose leukemia has returned or is difficult to treat. By testing their blood and bone marrow, doctors look for specific genetic markers to match them with the most promising experimental treatments. The goal is to improv…
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC